Highlights:
• $12.9M revenue already contracted for FY20; 16% increase on Q1 FY19;
• $2.5M of new contracts sold in Q1, adding $1.2M revenue to be recognised in FY20;
• Total sold revenue out to FY25 is $34.0M;
• Strategically important contract signed with Healthscope - first sale to a major private hospital
group of our data and analytics capabilities;
• Cash surplus from operations of $136K for Q1 FY20; representing the third consecutive quarter
of positive net cashflow; and improved cash reserves of $4.4M
Ann: Appendix 4C - quarterly, page-2
Add ALC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.002(3.70%) |
Mkt cap ! $69.80M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.5¢ | 5.1¢ | $28.06K | 533.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 58989 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 40999 | 2 |
View Market Depth
| Last trade - 16.10pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.2¢ |
Change
-0.002 ( 3.70 %) |
||||
| Open | High | Low | Volume | ||
| 5.3¢ | 5.4¢ | 5.1¢ | 399592 | ||
| Last updated 15.57pm 01/05/2024 ? | |||||
| ALC (ASX) Chart |